Inventor

Zhongguo Wang

Inventor
Lexington, MA, US

Overview

35→
Patents
2000–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 35 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07CAcyclic or carbocyclic compounds2%
C07HSugars1%
C40BCombinatorial chemistry1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,875,848Inhibiting fatty acid synthase (FASN)202010,807,976Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors202010,772,874Compounds and compositions for the inhibition of NAMPT202010,696,692Amido-benzyl sulfone and sulfoxide derivates202010,675,274Activating pyruvate kinase R202010,647,695Compounds and compositions for the inhibition of NAMPT202010,577,329Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors202010,550,098Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors202010,550,099Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors202010,456,382Compounds and compositions for the inhibition of NAMPT201910,414,752Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors201910,407,419Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors201910,399,980Purinones as ubiquitin-specific protease 1 inhibitors201910,329,275Compounds and compositions for the inhibition of NAMPT201910,294,206Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors201910,280,150Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors201910,272,072Compounds and compositions for the inhibition of NAMPT201910,266,495Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors201910,253,015Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors201910,189,841Purinones as ubiquitin-specific protease 1 inhibitors201910,005,734Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors20189,834,539Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors20179,815,817'Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors'20179,771,349'Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors'20179,676,721'Compounds and compositions for the inhibition of NAMPT'20179,624,216'Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors'20179,624,175'Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors'20179,555,039'Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)'20179,169,209'Compounds and compositions for the inhibition of NAMPT'20158,546,557'Methods of making nucleoside tetraphosphate analogs'20138,097,619'Inhibitors of cyclin-dependent kinases, compositions and uses related thereto'20127,893,057'Inhibitors of cyclin-dependent kinases, compositions and uses related thereto'20117,786,112'Inhibitors of cyclin-dependent kinases, compositions and uses related thereto'20107,605,175'Inhibitors of cyclin-dependent kinases, compositions and uses related thereto'20096,153,645'Heterocycles as antimicrobial agents'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000Based in Malden, MA, US· patent location history
2009–2020Based in Lexington, MA, US· patent location history
2012–2017Patents assigned to WANG ZHONGGUO (5)· patent assignee history
2015–2020Patents assigned to FORMA TM LLC (9)· patent assignee history
2015–2020Based in Watertown, MA, US· patent location history
2017–2020Patents assigned to FORMA THERAPEUTICS INC (16)· patent assignee history
2019–2020Patents assigned to GENENTECH INC (6)· patent assignee history
2019Patents assigned to FORMA TM2 INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
FORMA THERAPEUTICS INC162017–2020
FORMA TM LLC92015–2020
GENENTECH INC62019–2020
WANG ZHONGGUOself52012–2017
FORMA TM2 INC42019
Locations
LocationPatentsSpan
Lexington, Massachusetts, US302009–2020
Watertown, Massachusetts, US42015–2020
Malden, Massachusetts, US12000